George Lawrence Mikan III - 14 Dec 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Signature
/s/ Eric Halverson for George Lawrence Mikan III, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
14 Dec 2024
Net transactions value
-$70,237
Form type
4
Filing time
18 Dec 2024, 21:15:02 UTC
Previous filing
06 May 2024
Next filing
03 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise +35,000 +54% 99,832 14 Dec 2024 Direct F1
transaction NEUE Common Stock Sale $70,237 -16,803 -17% $4.18 83,029 17 Dec 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -35,000 -100% $0.000000 0 14 Dec 2024 Common Stock 35,000 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.99 to $4.60 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 60% of the restricted stock units awarded vested on the 2nd anniversary of the grant date and 40% vested on the 3rd anniversary of the grant date.